Volume 2  Issue 1 

Volume 2  Issue 1 


 Review Article
Atrophic Vaginitis in Breast Cancer Survivors: A Difficult Survivorship Issue

Joanne L. Lester*, PhD, CNP, AOCN, Gaurav Pahouja, Barbara L. Andersen, PhD, Maryam B. Lustberg, MD, MPH

Management of breast cancer includes systematic therapies including chemotherapy and endocrine therapy, can lead to a variety of symptoms that can impair the quality of life of many breast cancer survivors. Atrophic vaginitis, caused by decreased levels of circulating estrogen to urinary and vaginal receptors, is commonly experienced by this group. Chemotherapy induced ovarian failure and endocrine therapies including aromatase inhibitors and selective estrogen receptor modulators can trigger the onset of atrophic vaginitis or exacerbate existing symptoms.

Full text   Download PDF

Case Report
Minilaparoscopic Total Hysterectomy

Melahat Atasever, Emine Demirel, Sefa Kelekci

Minimally invasive surgery is now the cornerstone of gynecologic surgeries. Minilaparoscopic surgery is a new promising technique that involves the use of instruments with an external diameter of around 3 mm in contrast to standard sizes of 5-10 mm used in conventional procedures. In minilaparoscopic process, minimal invasive surgery is being more advanced, ports and surgical equipment’s are getting smaller in size. Although the sizes of equipment are getting smaller, the prevention of surgical standards is one of the most important goals.

Full textDownload PDF